CCA
CDNA icon

Conestoga Capital Advisors’s CareDx CDNA Stock Holding History

Conestoga Capital Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-580,533
Closed -$9.88M – 133
2022
Q3 		$9.88M Sell
580,533
-369,165
-39% -$7.92M 0.19% 68
2022
Q2 		$20.4M Sell
949,698
-374,075
-28% -$10.4M 0.37% 53
2022
Q1 		$49M Buy
1,323,773
+51,000
+4% +$1.99M 0.74% 45
2021
Q4 		$57.9M Buy
1,272,773
+240,415
+23% +$12.5M 0.75% 44
2021
Q3 		$65.4M Buy
1,032,358
+684,171
+196% +$52.1M 0.91% 41
2021
Q2 		$31.9M Buy
+348,187
New +$27.7M 0.46% 51
2021
Q1 		– Sell
-27,225
Closed -$1.97M – 144
2020
Q4 		$1.97M Sell
27,225
-20,930
-43% -$1.21M 0.03% 75
2020
Q3 		$1.83M Buy
48,155
+2,650
+6% +$89.5K 0.04% 75
2020
Q2 		$1.61M Buy
45,505
+19,200
+73% +$546K 0.04% 74
2020
Q1 		$574K Sell
26,305
-7,100
-21% -$159K 0.02% 93
2019
Q4 		$721K Buy
33,405
+18,400
+123% +$422K 0.02% 90
2019
Q3 		$339K Buy
15,005
+3,900
+35% +$108K 0.01% 117
2019
Q2 		$400K Sell
11,105
-1,990
-15% -$63.7K 0.01% 108
2019
Q1 		$413K Buy
+13,095
New +$382K 0.01% 103

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Conestoga Capital Advisors's CDNA Position: Q4 2022 in Review

Conestoga Capital Advisors sold out of CareDx (CDNA) in Q4 2022, closing a stake of 580,533 shares — an estimated $9.88M sold.

Conestoga Capital Advisors first reported a position in CDNA in Q1 2019 and held it in 14 quarters. The position peaked at $65.4M in Q3 2021. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • Conestoga Capital Advisors reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • Conestoga Capital Advisors sold 580,533 CareDx shares in Q4 2022, an estimated $9.88M.
  • Conestoga Capital Advisors first reported a position in CareDx in Q1 2019 and held it in 14 quarters.
  • Conestoga Capital Advisors's CareDx position peaked at $65.4M in Q3 2021.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Conestoga Capital Advisors's 13F filing for Q4 2022, filed 1 Feb 2023.